• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎患者循环维生素 D 水平状况与临床预后指标。

Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients.

机构信息

Respiratory Unit, Sant'Andrea Hospital, Sapienza University of Rome, Via di grottarossa, 1035, Rome, Italy.

Sant'Andrea Hospital, Rome, Italy.

出版信息

Respir Res. 2021 Mar 3;22(1):76. doi: 10.1186/s12931-021-01666-3.

DOI:10.1186/s12931-021-01666-3
PMID:33658032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7928197/
Abstract

BACKGROUND

Several immune mechanisms activate in COVID-19 pathogenesis. Usually, coronavirus infection is characterized by dysregulated host immune responses, interleukine-6 increase, hyper-activation of cytotoxic CD8 T lymphocytes. Interestingly, Vitamin D deficiency has been often associated with altered immune responses and infections. In the present study, we evaluated Vitamin D plasma levels in patients affected with different lung involvement during COVID-19 infection.

METHODS

Lymphocyte phenotypes were assessed by flow cytometry. Thoracic CT scan involvement was obtained by an image analysis program.

RESULTS

Vitamin D levels were deficient in (80%) of patients, insufficient in (6.5%) and normal in (13.5%). Patients with very low Vitamin D plasma levels had more elevated D-Dimer values, a more elevated B lymphocyte cell count, a reduction of CD8 + T lymphocytes with a low CD4/CD8 ratio, more compromised clinical findings (measured by LIPI and SOFA scores) and thoracic CT scan involvement.

CONCLUSIONS

Vitamin D deficiency is associated with compromised inflammatory responses and higher pulmonary involvement in COVID-19 affected patients. Vitamin D assessment, during COVID-19 infection, could be a useful analysis for possible therapeutic interventions.

TRIAL REGISTRATION

'retrospectively registered'.

摘要

背景

COVID-19 发病机制中存在几种免疫机制。通常,冠状病毒感染的特征是宿主免疫反应失调、白细胞介素 6 增加、细胞毒性 CD8 T 淋巴细胞过度激活。有趣的是,维生素 D 缺乏常与免疫反应改变和感染有关。在本研究中,我们评估了 COVID-19 感染期间不同肺部受累患者的血浆维生素 D 水平。

方法

通过流式细胞术评估淋巴细胞表型。通过图像分析程序获得胸部 CT 扫描受累情况。

结果

80%的患者存在维生素 D 水平不足,6.5%的患者存在维生素 D 水平不足,13.5%的患者存在维生素 D 水平正常。血浆维生素 D 水平极低的患者 D-二聚体值更高,B 淋巴细胞计数更高,CD8+T 淋巴细胞减少,CD4/CD8 比值降低,临床症状更严重(通过 LIPI 和 SOFA 评分测量),胸部 CT 扫描受累更严重。

结论

维生素 D 缺乏与 COVID-19 感染患者炎症反应受损和更高的肺部受累有关。在 COVID-19 感染期间评估维生素 D 水平可能是一种有用的分析方法,用于可能的治疗干预。

试验注册

“回顾性注册”。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a9b/7931550/65ccd6a69256/12931_2021_1666_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a9b/7931550/85e89b1bec5a/12931_2021_1666_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a9b/7931550/eb3fc0bf72d2/12931_2021_1666_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a9b/7931550/65ccd6a69256/12931_2021_1666_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a9b/7931550/85e89b1bec5a/12931_2021_1666_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a9b/7931550/eb3fc0bf72d2/12931_2021_1666_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a9b/7931550/65ccd6a69256/12931_2021_1666_Fig3_HTML.jpg

相似文献

1
Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients.新型冠状病毒肺炎患者循环维生素 D 水平状况与临床预后指标。
Respir Res. 2021 Mar 3;22(1):76. doi: 10.1186/s12931-021-01666-3.
2
Vitamin D and Lung Outcomes in Elderly COVID-19 Patients.维生素 D 与老年 COVID-19 患者的肺部结局
Nutrients. 2021 Feb 24;13(3):717. doi: 10.3390/nu13030717.
3
Vitamin D and disease severity in coronavirus disease 19 (COVID-19).维生素 D 与 19 型冠状病毒疾病(COVID-19)的疾病严重程度。
Reumatismo. 2021 Jan 18;72(4):189-196. doi: 10.4081/reumatismo.2020.1333.
4
Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease.维生素 D 缺乏与 COVID-19 阳性和疾病严重程度有关。
J Med Virol. 2021 May;93(5):2992-2999. doi: 10.1002/jmv.26832. Epub 2021 Feb 9.
5
Vitamin D plasma levels in patients with COVID-19: a case series.COVID-19 患者的维生素 D 血浆水平:一项病例系列研究。
Infez Med. 2021 Jun 1;29(2):224-228.
6
Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19.入住 ICU 的 COVID-19 患者维生素 D 水平低,中性粒细胞增多。
Clin Nutr ESPEN. 2021 Aug;44:466-468. doi: 10.1016/j.clnesp.2021.05.021. Epub 2021 May 31.
7
Prevalence and Clinical Outcomes of Vitamin D Deficiency in COVID-19 Hospitalized Patients: A Retrospective Single-Center Analysis.COVID-19住院患者维生素D缺乏的患病率及临床结局:一项回顾性单中心分析
Tohoku J Exp Med. 2021 Oct;255(2):127-134. doi: 10.1620/tjem.255.127.
8
The Biochemical Parameters and Vitamin D Levels in ICU Patients with Covid-19: A Cross-Sectional Study.《COVID-19 重症监护病房患者的生化参数和维生素 D 水平:一项横断面研究》。
Endocr Metab Immune Disord Drug Targets. 2021;21(12):2191-2202. doi: 10.2174/1871530321666210316103403.
9
Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients.给编辑的信:COVID-19 患者急性疾病期间的维生素 D 水平与临床严重程度。
Respir Res. 2021 Apr 9;22(1):102. doi: 10.1186/s12931-021-01703-1.
10
Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies.维生素 D 对 COVID-19 感染的治疗和预后作用:43 项观察性研究的系统评价和荟萃分析。
J Steroid Biochem Mol Biol. 2021 Jul;211:105883. doi: 10.1016/j.jsbmb.2021.105883. Epub 2021 Mar 26.

引用本文的文献

1
Genetic Evidence Indicates that Serum Micronutrient Levels Mediate the Causal Relationships Between Immune Cells and Neuropathic Pain: A Mediation Mendelian Randomization Study.遗传证据表明血清微量营养素水平介导免疫细胞与神经性疼痛之间的因果关系:一项中介孟德尔随机化研究。
Mol Neurobiol. 2025 Mar 3. doi: 10.1007/s12035-025-04805-9.
2
Vitamin D and COVID-19: comparative analysis with other respiratory infections and impact of comorbidities.维生素D与2019冠状病毒病:与其他呼吸道感染的比较分析及合并症的影响
Germs. 2024 Sep 30;14(3):232-245. doi: 10.18683/germs.2024.1435. eCollection 2024 Sep.
3
To Be Frail or Not to Be Frail: This Is the Question-A Critical Narrative Review of Frailty.

本文引用的文献

1
Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.BCG 疫苗接种不能预防 SARS-CoV-2,这一结论得到了流行病学分析的支持。
Sci Rep. 2020 Oct 27;10(1):18377. doi: 10.1038/s41598-020-75491-x.
2
Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results.维生素 D 状态与其他临床特征与 COVID-19 检测结果的关联。
JAMA Netw Open. 2020 Sep 1;3(9):e2019722. doi: 10.1001/jamanetworkopen.2020.19722.
3
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
衰弱与否:这是个问题——对衰弱的批判性叙述性综述
J Clin Med. 2024 Jan 26;13(3):721. doi: 10.3390/jcm13030721.
4
Vitamin D supplementation is beneficial in improving the prognosis of patients with acute respiratory failure in the intensive care unit: a retrospective study based on the MIMIC-IV database.维生素D补充剂有助于改善重症监护病房中急性呼吸衰竭患者的预后:一项基于MIMIC-IV数据库的回顾性研究。
Front Med (Lausanne). 2023 Nov 23;10:1271060. doi: 10.3389/fmed.2023.1271060. eCollection 2023.
5
Severity of oxidative stress as a hallmark in COVID-19 patients.氧化应激的严重程度作为 COVID-19 患者的特征之一。
Eur J Med Res. 2023 Dec 4;28(1):558. doi: 10.1186/s40001-023-01401-2.
6
Increasing Efficacy of Covid-19 Vaccines by Lifestyle Interventions.通过生活方式干预提高新冠疫苗的效果。
Arch Razi Inst. 2022 Oct 31;77(5):1527-1538. doi: 10.22092/ARI.2021.356491.1854. eCollection 2022 Oct.
7
The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity.血清 LL-37 水平与血白细胞计数的比值与 COVID-19 的严重程度相关。
Sci Rep. 2022 Jun 8;12(1):9447. doi: 10.1038/s41598-022-13260-8.
8
Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients' Outcomes-A Single-Center Experience and a Brief Review of the Literature.COVID-19 患者血清维生素 D 水平低与炎症标志物和患者预后无关:一项单中心经验及文献复习。
Nutrients. 2022 May 10;14(10):1998. doi: 10.3390/nu14101998.
9
Nonthyroidal Illness Syndrome: To Treat or Not to Treat? Have We Answered the Question? A Review of Metanalyses.非甲状腺疾病综合征:治疗还是不治疗?我们是否已经回答了这个问题?荟萃分析综述。
Front Endocrinol (Lausanne). 2022 May 10;13:850328. doi: 10.3389/fendo.2022.850328. eCollection 2022.
10
Vitamin D can reduce severity in COVID-19 through regulation of PD-L1.维生素 D 通过调控 PD-L1 可以减轻 COVID-19 的严重程度。
Naunyn Schmiedebergs Arch Pharmacol. 2022 Apr;395(4):487-494. doi: 10.1007/s00210-022-02210-w. Epub 2022 Jan 31.
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
4
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.新型冠状病毒肺炎患者支气管肺泡灌洗液和外周血单个核细胞的转录组学特征。
Emerg Microbes Infect. 2020 Dec;9(1):761-770. doi: 10.1080/22221751.2020.1747363.
5
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?新冠病毒感染中针对过度炎症反应的免疫抑制:一把双刃剑?
Lancet. 2020 Apr 4;395(10230):1111. doi: 10.1016/S0140-6736(20)30691-7. Epub 2020 Mar 24.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer.肺免疫预后指数对转移性非小细胞肺癌患者的预后价值
JAMA Oncol. 2019 Oct 1;5(10):1481-1485. doi: 10.1001/jamaoncol.2019.1747.
8
Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response.维生素 D 作为介导类风湿关节炎免疫反应的主要因素。
Biomed Res Int. 2019 May 7;2019:3494937. doi: 10.1155/2019/3494937. eCollection 2019.
9
Non-specific effects of BCG vaccine on viral infections.卡介苗疫苗对病毒感染的非特异性作用。
Clin Microbiol Infect. 2019 Dec;25(12):1473-1478. doi: 10.1016/j.cmi.2019.04.020. Epub 2019 May 2.
10
Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial.维生素 D 补充对缺乏老年人流感疫苗反应和免疫功能的影响:一项随机安慰剂对照试验。
Front Immunol. 2019 Feb 8;10:65. doi: 10.3389/fimmu.2019.00065. eCollection 2019.